Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8786851 | 0.86 | ATM (0.34) | CYP19A1SIGMAR1 | |
| SCHEMBL5095282 | 0.86 | ATM (0.34) | CYP19A1SIGMAR1 | |
| SCHEMBL5095470 | 0.86 | ATM (0.34) | CYP19A1SIGMAR1 | |
| SCHEMBL9738223 | 0.84 | CYP19A1 (0.42) | CYP19A1SIGMAR1 | |
| SCHEMBL9130961 | 0.84 | CYP19A1 (0.42) | CYP19A1SIGMAR1 | |
| SCHEMBL9687167 | 0.83 | CHRM1 (0.38) | CYP19A1SIGMAR1 | |
| SCHEMBL9617147 | 0.83 | CHRM1 (0.38) | CYP19A1SIGMAR1 | |
| SCHEMBL9567071 | 0.82 | — | — | |
| SCHEMBL9381282 | 0.81 | SIGMAR1 (0.34) | CYP19A1SIGMAR1 | |
| SCHEMBL8805757 | 0.81 | SIGMAR1 (0.33) | CYP19A1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050004092-A1 | Penem derivatives and antimicrobial agent containing the same | DAIICHI SUNTORY PHARMA CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-0757051-B1 | PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME | DAIICHI SUNTORY PHARMA CO LTD (JP) | 2003-10-29 | — | — | EP | disclosed |
| EP-0757051-A1 | PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME | SUNTORY LIMITED (JP) | 1997-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004092-A1 | Penem derivatives and antimicrobial agent containing the same | MRPL21, MRPS2, MRPS28 | CYP19A1 4312/4885SIGMAR1 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.